CHRISTINA REBIC: Open Payments
NPI 1275003964 · BEDFORD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 43 payments from 13 companies in 2025. Trend: 2023 $63 · 2024 $195 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $342 |
| Regeneron Pharmaceuticals, Inc. | 1 | $150 |
| Exact Sciences Corporation | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Lilly USA, LLC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: QULIPTA, DUPIXENT, UBRELVY, The Cologuard Plus Collection Kit, XIFAXAN, ELIQUIS, AIRSUPRA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
